Back to Incyte

Incyte News

INCY

Incyte Reaches Jakafi Medicaid Pricing Deal

Incyte (INCY) and CMS agree Medicaid pricing terms for Jakafi; potential implications for Medicaid rebates, JAKAFI revenue concentration and financial estimates.

31 August 2026INCYTE CORP
INCY

Incyte Completes Vega Therapeutics Deal

Incyte (INCY) closes acquisition of Vega Therapeutics subsidiary on Jul 6, 2026. Deal aligns with pipeline strategy; cash+marketables $3.6B (12/31/2025).

6 July 2026INCYTE CORP
All news